{"id":"W2804803500","doi":"10.1200/edbk_200679","title":"New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Pembrolizumab; Nivolumab; Hodgkin lymphoma; Clinical trial; Intensive care medicine; Disease; Oncology; Lymphoma; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001019171,0.0006311667,0.001227071,0.002218869,0.0003332394,0.001352919,0.001115808,0.001306057,0.003679026],"category_scores_gemma":[0.00276728,0.0003110049,0.0005759757,0.00295792,0.0008154927,0.002830214,0.0006703687,0.003142903,0.001935507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001231841,"about_ca_system_score_gemma":0.001706663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001911648,"about_ca_topic_score_gemma":0.003935063,"domain_scores_codex":[0.9995424,0.0001160678,0.00008587437,0.00005048505,0.0001773716,0.0000278045],"domain_scores_gemma":[0.9987522,0.000624787,0.0001700014,0.00003362734,0.0003499775,0.00006941039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003537827,0.00003168543,0.0001387735,0.01374166,0.00006406739,0.0001216623,0.00009610045,0.0002711125,0.0002185415,0.004776523,0.1388087,0.8416957],"study_design_scores_gemma":[0.00001350583,0.00002891743,0.0004178212,0.008316906,0.00007129175,0.0009517377,0.00008999763,0.00006270815,0.00005378829,0.002779133,0.9872005,0.00001363364],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003625787,0.9970171,0.00009631962,0.00146327,0.0006839767,0.000003185191,0.00001021552,0.000007174066,0.000682454],"genre_scores_gemma":[0.0005388344,0.9959287,0.0003079582,0.001680311,0.0008268373,0.000006499189,0.0000311344,0.000003132246,0.0006766258],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003679026,"threshold_uncertainty_score":0.01230758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2095668149700712,"score_gpt":0.5368109536088498,"score_spread":0.3272441386387785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}